In most settings, currently available coronavirus disease 2019 (COVID-19) vaccines offer protection against hospitalization and…
View More Does previous SARS-CoV-2 infection affect vaccine-induced immunity?
Home »
Vaccinating previously infected induces more potent antibodies less susceptible to escape from SARS-CoV-2 variants
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019…
View More Vaccinating previously infected induces more potent antibodies less susceptible to escape from SARS-CoV-2 variants
Oh deer! Antibodies to SARS-CoV-2 detected in 40% of wild white-tailed deer in four U.S. states
Researchers conducting a serosurveillance study of a North American deer species have provided evidence of…
View More Oh deer! Antibodies to SARS-CoV-2 detected in 40% of wild white-tailed deer in four U.S. states
COVID antibodies from vaccination are almost 3 times higher than from infection
(HealthDay)—People who’ve been fully vaccinated against COVID-19 have a much stronger immune system response against…
View More COVID antibodies from vaccination are almost 3 times higher than from infection
Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has…
View More Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities
New method to transport RNA-based drugs to subpopulation of immune cells
Tel Aviv University's groundbreaking technology may revolutionize the treatment of cancer and a wide range…
View More New method to transport RNA-based drugs to subpopulation of immune cells
Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?
Among the intriguing aspects of the current pandemic of coronavirus disease 2019 (COVID-19), caused by…
View More Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?
Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants
In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from…
View More Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants
What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?
Over a year on since the coronavirus disease 2019 (COVID-19) pandemic began, evidence from studies…
View More What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?
The potential of mRNA vaccines for a wide range of diseases
Vaccination is an important strategy to prevent the transmission of various infectious diseases such as…
View More The potential of mRNA vaccines for a wide range of diseases